Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Beat Estimates
Portfolio Pulse from
Collegium Pharmaceutical (COLL) reported Q4 earnings of $1.77 per share, surpassing the Zacks Consensus Estimate of $1.54. This marks an improvement from last year's $1.58 per share.
February 28, 2025 | 12:00 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Collegium Pharmaceutical reported Q4 earnings of $1.77 per share, exceeding expectations and showing growth from the previous year.
The earnings beat and year-over-year growth are positive indicators for Collegium Pharmaceutical, likely leading to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100